When combined with neuroimaging findings and clinical scales such as the NIHSS and ASPECTS, certain biomarkers, such as NT-proBNP, troponin, and IL-6 may help predict infarct volume and stroke severity. This evidence concerns the gene IL6 and stroke disorder.